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Like many promising drug targets, phosphoethanolamine methyltransferase is part of a pathway that is
present in a pathogen but not inmammalian hosts. In this issue of Structure, Lee and Jez describe a structure
of this phospholipid biosynthesis enzyme from a parasitic nematode and reveal a reconfigured active site.Billions of the world’s poorest people are
afflicted by pathogenic nematodes, in-
cluding some horrifying parasites. In com-
munities of the Global North, the main
reminder of the worm scourge is the
need to give the family dog ivermectin to
prevent heartworm. If heartworm para-
sites mature, the dog will need an arsen-
ical drug not too different from Paul
Ehrlich’s Salvarsan, the first chemothera-
peutic agent. Brutal side effects limit the
medical use of arsenical drugs to the dir-
est infections of the Global South, suchCho
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Figure 1. Phosphatidylcholine Biosynthesis in Eukaryotes
The Kennedy pathway (orange line), the primary source of human phos-
phatidylcholine (PtdCho), requires the essential nutrient choline (Cho). The
Bremer-Greenberg pathway (red line) is an alternative route in which a mem-
brane-bound pEA N-methyltransferase (PEMT) does all three methylations.
Humans do not possess the phosphobase methyltransferase (MT) pathway
(green line), which is used by plants, protozoa, and nematodes. The phospho-
base methylation pathway relies on part of the Kennedy pathway.as the sleeping sickness
trypanosome, which cannot
be cured any other way.
Shared biochemistry makes
it tough to target eukaryotic
parasites; they are too similar
to their eukaryotic hosts. To
succeed, we must first iden-
tify significant differencesand
vulnerabilities in the parasite
and then, as Ehrlich (1909)
said, ‘‘wir mu¨ssen zielen ler-
nen, chemisch zielen lernen!’’
(‘‘we must learn to aim, learn
to aim chemically!’’).
In this issue of Structure,
Lee and Jez (2013) follow
Ehrlich’s advice in a study
of phospholipid biosynthesis
in the barber pole worm
Haemonchus contortus. This
gastrointestinal bloodsucker
affects ruminant livestock,
mainly sheep, and causes
substantial economic losses
worldwide. H. contortus is
notoriously prolific and quick
to develop resistance to
antihelmintic drugs like iver-
mectin (Gilleard, 2006). New
targets and new drugs areneeded to keep pace with parasite
resistance.
The Kennedy pathway (Figure 1) con-
verts choline (Cho) into phosphatidyl-
choline (PtdCho), the most abundant
phospholipid in eukaryotic membranes
(Kent, 1995). An alternative route converts
phosphatidylethanolamine to PtdCho us-
ing S-adenosylmethionine (SAM)-depen-
dent methyltransferase (MT) reactions.
Plants, as usual, make it from scratch.
Phosphoethanolamine (pEA) is converted
to phospho-Cho (pCho) by soluble pEAStructure 21, October 8, 2013methyltransferases (PMTs). Plant-like
PMTs are required for the growth of the
malaria parasite Plasmodium falciparum
and nematodes (Palavalli, et al., 2006;
Witola, et al., 2008). Since the phospho-
base methylation pathway is not pre-
sent in humans, PMT inhibitors have the
potential to be selective antiparasite
drugs.
Protozoan PMTs perform all three
phosphobase methylations using a single
MT domain. In malaria PMT (PfPMT), the
amine that attacks the electrophilic SAMª2013 Elsevmethyl group is deprotonated
by a tyrosine, which is in turn
polarized by a histidine (Lee,
et al., 2012). Curiously, the
histidine may be the more
important part of the catalytic
dyad. Nematode PMT1 per-
forms the first methylation
(pEA to pMME), and PMT2
performs the other two meth-
ylations (pMME to pCho)
(Lee, et al., 2011). Each PMT
contains two MT domains,
only one of which is func-
tional. X-ray crystal structures
show the same catalytic
dyad is present in similar
PfPMT and H. contortus
PMT2 (HcPMT2) active sites.
In addition, a single residue
may enable HcPMT2 to reject
pEA as a substrate. New
enzymes evolve by gene
duplication and diversifica-
tion. If the ancestral form is a
multispecific (promiscuous)
enzyme, only a few mutations
may be required for new func-
tions to emerge (Khersonsky
and Tawfik, 2010). We gener-
ally expect, however, that theier Ltd All rights reserved 1719
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Previewsbasic active site layout and enzyme
mechanism will be conserved.
Not so here. The surprise is that
HcPMT1 has jettisoned the catalytic
dyad entirely. The pEA phosphate, not
histidine, activates the tyrosine general
base by way of a water molecule. The
tyrosine is provided by a different part
of the MT domain, and it approaches
the phosphobase amine from an orthog-
onal direction, relative to the substrates.
Moreover, the switch to substrate-
assisted catalysis clearly alters local
electrostatics. If this doesn’t amount
to a genuinely new mechanism for
carbon-nitrogen bond formation—the
enzymological data that might settle the
question are not in hand—it comes right
up to that edge. At a minimum, the
versatile MT domain is even more plastic
than previously realized (Liscombe,
et al., 2012).
Those who wish to inhibit phosphobase
methylations in parasitic nematodes now
know to look for more than one inhibitor.
If binding site rigidity correlates with sub-
strate specificity, it may be easier to find1720 Structure 21, October 8, 2013 ª2013 Elhigh-affinity ligands for HcPMT1 than the
promiscuous PMTs.
Like all good science, the work by Lee
and Jez (2013) raises questions without
obvious answers, such as: ‘‘why muck
with a perfectly good active site’’? The
HcPMT1 pEA kcat/KM is not tremendously
higher than in promiscuous PMTs (Lee,
et al., 2011). Tyrosine-to-phenylalanine
mutants are nowhere near dead (Lee,
et al., 2012; Lee and Jez, 2013); maybe
it is enough to point an amine at the
business end of SAM? If catalytic rational-
izations are unsatisfying, we are left to
ponder fanciful regulatory schemes. In
that context, it may be relevant that both
HcPMTs contain a ‘‘vestigial’’ MT domain
that cannot bind SAM. Like a modern city
built on its predecessor, it can be difficult
to tell if the derelict twin is just a structural
support or if it contains useful hidden
infrastructure.ACKNOWLEDGMENTS
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In this issueofStructure, Lyumkis andcolleaguesdescribeahigh resolution structureof apolymerized formof
theSgrAI restrictionenzyme,which shows that it formsahelical assemblywith four enzymemoleculesper turn
of the helix. The DNA is arranged on the periphery of the protein helix pointing away from the helical axis.Classically, a restrictionendonuclease (RE-
ase) or restriction enzyme is defined by the
natureof itsDNArecognitionsequenceand
where the enzyme cleaves DNA containing
the recognition sequence (Roberts et al.,
2003). The most widely used REases
recognize short palindromic sequences
and cleave at the sequence to generate
blunt or sticky ends suitable for further ma-
nipulations. These simpleREasesare in the
Type IIP class, and their structures showed
a simple homodimer, with each monomer
recognizing half of the recognitionsequence (see REBASE for links to struc-
tures; Roberts et al., 2010). This perception
of REases as homodimers dominates text-
book descriptions and the commonway of
thinking about REases.
However, since the first atomic struc-
tures, REases have been found to show a
very largenumberofdifferentarchitectures.
REases have been found as monomers,
homo-dimers and hetero-dimers, hetero-
trimers, homo-tetramers and hetero-tetra-
mers, hetero-pentamers, andeven tetrade-
camers (seeREBASE for links tostructures;Roberts et al., 2010). These complexes
may not even be the most active form of
the REase.Many REases show optimal ac-
tivity only when two or more copies of the
recognition sequence are present, indi-
cating that higher order complexes form
when the enzymes bind toDNA (e.g., Smith
et al., 2013). Imaging techniques have
shownmanyexamples of loopsofDNAbe-
ing formed by these higher order REase
structures (e.g., Shlyakhtenko et al., 2007).
Nancy Horton and her colleagues have
been studying the SgrAI REase from
